PARMAR, Mitulkumar T. Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025. International Journal of Engineering and Management Research, [S. l.], v. 16, n. 3, p. 113–125, 2026. DOI: 10.31033/IJEMR/16.3.2026.1941. Disponível em: https://ijemr.vandanapublications.com/index.php/j/article/view/1941. Acesso em: 28 sep. 2026.